ReviewGlobal health research and policy2021
Can Africa achieve herd immunity?
Review in Global health research and policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- COVID-19 vaccination intention among internally displaced persons in complex humanitarian emergency context, Northeast Nigeria.PloS one · 2024Article
- Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa?Risk management and healthcare policy · 2024Article
- Will Cape Verde attain COVID-19 herd immunity? Progress, Challenges, and Recommendations.Public health challenges · 2023Article
- Achieving COVID-19 herd immunity in Ethiopia.Public health challenges · 2023Article
- Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity.Vaccines · 2023Review
- Achieving COVID-19 herd immunity in Algeria: Current state of vaccination, challenges, and recommendations.Public health challenges · 2023Article
- Achieving herd immunity in South America.Global health research and policy · 2023Article
- Road to achieving COVID-19 herd immunity in Niger Republic: Challenges and recommendations.Public health challenges · 2022Article
- Towards a post-COVID world: Challenges and progress of recovery in Kazakhstan.Public health challenges · 2022Article
- Why many African countries may not achieve the 2022 COVID-19 vaccination coverage target.Tropical medicine and health · 2022Article
- Public Health Emergence: Challenges and Prospects for the Future of Herd Immunity to Reduce the Negative Impact of Disease X in Low- and Middle-Income Countries.Clinical pathology (Thousand Oaks, Ventura County, Calif.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization described herd immunity, also known as population immunity, as the indirect fortification from an infectious disease that happens when a population is immune either through vaccination or immunity developed through previous exposure to infection. The emergence of COVID-19 vaccine is a step towards the achievement of herd immunity. Over one billion people across the globe have been vaccinated and Africa recorded only 2%. The objective of this article was to develop a forecast of the number of people to be vaccinated to achieve herd immunity in the 13 WHO-identified priority African countries for COVID-19. Herd immunity is achieved when one infected person in a population causes less than one secondary case on average, corresponding to the effective basic reproduction number (R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.